Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4607]

FDA approves ivosidenib for advanced or metastatic cholangiocarcinoma

FDA approves ivosidenib for advanced or metastatic cholangiocarcinoma

Innovative ICR-discovered drug to enter first clinical trial, targeting HSF1 pathway

Innovative ICR-discovered drug to enter first clinical trial, targeting HSF1 pathway

An existing drug opens new possibilities for treating child leukaemia

An existing drug opens new possibilities for treating child leukaemia

For cancer care, patients’ relationship with their primary care providers prove crucial

For cancer care, patients’ relationship with their primary care providers prove crucial

Researchers developing new cancer treatments with high-intensity focused ultrasound

Researchers developing new cancer treatments with high-intensity focused ultrasound

Inducing apoptosis and enhancing cytoprotective autophagy in colon cancer

Inducing apoptosis and enhancing cytoprotective autophagy in colon cancer

UT Southwestern pioneers PULSAR-integrated radiotherapy with immunotherapy for improved tumour control

UT Southwestern pioneers PULSAR-integrated radiotherapy with immunotherapy for improved tumour control

FDA approves nivolumab for adjuvant treatment of urothelial carcinoma

FDA approves nivolumab for adjuvant treatment of urothelial carcinoma

New research identifies genomic markers of aggressive childhood leukaemias

New research identifies genomic markers of aggressive childhood leukaemias

Blood-pressure drugs could improve colorectal cancer survival, study suggests

Blood-pressure drugs could improve colorectal cancer survival, study suggests

More from ecancer